Major Depressive Disorder With Mixed Features - Extension
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with
mixed features.This clinical study is designed to test how well Lurasidone works to treat
major depressive disorder with mixed features over time.